Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
10.08
+2.66 (35.96%)
At close: Jun 24, 2026, 4:00 PM EDT
10.10
+0.03 (0.25%)
After-hours: Jun 24, 2026, 4:33 PM EDT
Absci Employees
Absci had 140 employees as of December 31, 2025. The number of employees decreased by 17 or -10.83% compared to the previous year.
Employees
140
Change (1Y)
-17
Growth (1Y)
-10.83%
Revenue / Employee
$13,114
Profits / Employee
-$845,971
Market Cap
1.57B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 140 | -17 | -10.83% | 140 | 0 |
| Dec 31, 2024 | 157 | 1 | 0.64% | 156 | 1 |
| Dec 31, 2023 | 156 | -37 | -19.17% | 155 | 1 |
| Dec 31, 2022 | 193 | -19 | -8.96% | 193 | 0 |
| Dec 31, 2021 | 212 | 110 | 107.84% | 211 | 1 |
| Sep 30, 2021 | 207 | 105 | 102.94% | 207 | 0 |
| Jun 30, 2021 | 169 | - | - | 169 | 0 |
| Mar 31, 2021 | 102 | - | - | 102 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Ascentage Pharma Group International | 767 |
| Immunocore Holdings | 524 |
| Ardelyx | 489 |
| Maravai LifeSciences Holdings | 416 |
| Maze Therapeutics | 141 |
| Septerna | 130 |
| AtaiBeckley | 99 |
ABSI News
- 9 hours ago - Absci prices 13.5M shares at $7.41 in public offering - TheFly
- 10 hours ago - Absci reports Phase 1 data from human trial of ABS-201 - TheFly
- 10 hours ago - Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors - GlobeNewsWire
- 10 hours ago - Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) - GlobeNewsWire
- 9 days ago - Absci price target raised to $15 from $10 at Guggenheim - TheFly
- 12 days ago - MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery - Business Wire
- 15 days ago - Absci Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 15 days ago - Absci Slides: FY 2026 - Filings